期刊文献+

抗人P185^(erbB2)单抗C25的生物活性及其可变区基因的克隆 被引量:1

Active identification of an anti human P185^(erbB2) McAb C25 and cloning of its variable region genes
下载PDF
导出
摘要 了解抗人P185erbB2单抗C25的生物学活性,并克隆其可变区基因 ,为研制抗人P185erbB2的人源化抗体奠定基础。方法 :以细胞ELISA、免疫组化等方法分析C25单抗的抗原结合特性 ,用MTT法检测其对乳腺癌细胞SKBR3、及卵巢癌细胞SKOV3 增殖的抑制作用及对化疗药的增敏作用。经RT PCR扩增C25单抗的轻、重链可变区基因 ,克隆后进行核苷酸序列分析。结果 :C25单抗能特异结合人P185erbB2胞外区抗原 ,可显著抑制SKBR3、SKOV3 细胞增殖 ,与顺铂具协同作用。抗体的轻链可变区基因327bp,属于小鼠κ轻链第Ⅲ亚群 ;重链可变区基因366bp属于小鼠IgG1第Ⅲ (A)亚群。结论 :C25单抗可显著抑制人P185erbB2过表达肿瘤细胞的增殖并与顺铂具协同作用 。 Objective: Among 10 strains of anti human P185erbB2 McAbs prepared earlier, C25 having high affinity was chosen to identify the activecharacters and clone its variable region genes, so as to construct humanized antibody Methods: The antigen recognition character of C25 was analyzed by cellular ELISA and immunohistochemistry Inhibitory effects of C25 alone and combinations with chemotherapeutic agents to proliferation of SKBR3 and SKOV3 cells were detected by MTT assay Genes of VH and VL were amplified from the total RNA ofthe C25 hybridoma by RT PCR,cloned into vectors,and then sequenced Results:C25 recognized extracellular domain of P185erbB2 specifically, inhibited proliferation of SKBR3 and SKOV3 cells significantly and had synergistic effect with CDDP The 327 bp VL gene of C25 belongs to mouse kappa light chain subclass Ⅲand rearrangement in VJκ2 type; the 366 bp VH gene of C25 belong to mouse IgG1heavy chain subgroup Ⅲ(A) and rearrangement in VDJH4 type Conclusions: McAbC25 can inhibit proliferation of cells overexpressing P185erbB2 significantly and have synergy with CDDP The nucleotide sequence analysis indicates that the cloned gene code VL and VH of McAb C25 respectively
出处 《癌症》 SCIE CAS CSCD 北大核心 2000年第8期735-738,共4页 Chinese Journal of Cancer
关键词 单克隆抗体 RT-PCR 可变区基因 抗人P185^erbB2 ErbB2 Monoclonal antibody RT PCR Variable region genes
  • 相关文献

参考文献4

二级参考文献1

  • 1杨治华,中国免疫学杂志,1999年,15卷,414页

共引文献1

同被引文献6

  • 1Arai S, Klingemann HG. Natural killer cells : can they be useful as adoptive immunotherapy for cancer [ J ] ? Expert Opin Biol Tber, 2005, 5 ( 2 ) : 163-172.
  • 2Uherek C, Tonn T, Uherek B, et al. Retargeting of natural killercell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction [ J ] . Blood, 2002, 100 ( 4 ) : 1265-1273.
  • 3Cartron G, Dacheux L, Salles G, et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene [ J ] . Blood, 2002, 99 ( 3 ) : 754-758.
  • 4Rouillard JM, Lee W, Truan G, et al. Gene2Oligo : oligonucleotide design for in vitro gene synthesis [ J ].Nucleic Acids Res, 2004, 32 : W176-WI80.
  • 5Hynes NE, Stern DF. The biology of erbB2/neu/HER2 and its role in cancer [ J ] . Biochim Biophys Acta, 1994, 1198 ( 6 ) : 165-184.
  • 6石燕,焦顺昌.天然免疫—肿瘤免疫治疗不容忽视的领域[J].现代肿瘤医学,2009,17(2):367-370. 被引量:5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部